Resources Contact Us Home
Modified leukotoxin protein

Image Number 15 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Vehicle front fender
Mobile electronic device
Method for repairing or replacing damaged tissue
Method and system for distributing load by redirecting traffic
Delay lines, amplifier systems, transconductance compensating systems and methods of compensating
Image capturing apparatus, control method thereof, and program
Methods for isolating ligands of the human bitter taste receptor TAS2R49
  Randomly Featured Patents
Underwater motive device
Former for fabricating a composite material casing for a gas turbine
Method for manufacturing non-volatile magnetic memory
Adjustable support device for level facility
High selectivity process for dehydrogenation of paraffinic hydrocarbons
Imaging apparatus, flash device, and control method thereof
Lock for sliding doors and windows
LTB.sub.4 as vaccine adjuvant
Liquid crystal display device having an improved lighting device
Process and device for permeation of biological objects